News & Articles

Expanded partnership aims to advance precision oncology through distributed NGS‑based tissue and liquid biopsy testing

A study led by Karl Landsteiner University shows that the disease affects whole-brain communication networks, and that this may help predict survival

A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible results

Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics

New portfolio enhancements reflect Bruker’s commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges

In research conducted in mice, scientists identified a trio of existing medicines as promising candidates for treating a rare and severe form of infant leukemia caused by a genetic changed called KMT2A::AFF1

Oxford researcher Nina Dimova pushes pixel-by-pixel calibration and clustering to unlock nanosecond precision in particle tracking and electron microscopy

Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026

Prospective study published in Clinical Cancer Research shows that women >70 who tested Signatera MRD-negative could avoid surgery and remain progression-free

Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies

Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets

Expanded CFTR variant coverage designed to align with updated professional recommendations

After years of research, gene therapy is entering clinics worldwide, bringing new expectations and new responsibilities for diagnostic laboratories

Collaboration aims to discover and develop antibodies against multiple therapeutic targets designated by Merck

The U.S. FDA has cleared the Investigational New Drug (IND) application for ABSK061, a highly selective small-molecule FGFR2/3 inhibitor, for the treatment of children with achondroplasia (ACH)

Equipped with the READY System to make structural biology research accessible to more labs

Guest editorial by Milestone explores the benefits of microwave technology in elemental analysis, organic contaminant testing, and nutritional and compositional profiling of food samples

Prospective UT MD Anderson study shows RNA analysis expands on treatment options beyond DNA testing

See how Honeywell and METTLER TOLEDO collaborated to unlock new frontiers for Hydranal reagent formulation via automated titration

Advancing efficiency and uptime in gas chromatography

Dr. Becky Upton, President of Pistoia Alliance, looks to the future of lab innovation in this guest editorial

How Roche and Disease Management Consulting empower laboratory professionals to drive strategic value in healthcare systems

Injecting nivolumab directly into precancerous oral lesions led to reduction in lesion size and allowed some patients to avoid surgery

Showcased at AACR 2026 with data from leading research institutions, including the June Lab at the Perelman School of Medicine, University of Pennsylvania and German Cancer Research Institute (DKFZ)

From spreadsheet silos to AI-powered insights, discover how Signals software is streamlining formulation science